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A timely determination of the risk of post-traumatic stress disorder (PTSD) is a prerequisite for efficient service delivery and prevention. 
We provide a risk estimate tool allowing a calculation of individuals’ PTSD likelihood from early predictors. Members of the International 
Consortium to Predict PTSD (ICPP) shared individual participants’ item-level data from ten longitudinal studies of civilian trauma survivors 
admitted to acute care centers in six countries. Eligible participants (N=2,473) completed an initial clinical assessment within 60 days of trauma 
exposure, and at least one follow-up assessment 4-15 months later. The Clinician-Administered PTSD Scale for DSM-IV (CAPS) evaluated 
PTSD symptom severity and diagnostic status at each assessment. Participants’ education, prior lifetime trauma exposure, marital status and 
socio-economic status were assessed and harmonized across studies. The study’s main outcome was the likelihood of a follow-up PTSD given 
early predictors. The prevalence of follow-up PTSD was 11.8% (9.2% for male participants and 16.4% for females). A logistic model using early 
PTSD symptom severity (initial CAPS total score) as a predictor produced remarkably accurate estimates of follow-up PTSD (predicted vs. raw 
probabilities: r=0.976). Adding respondents’ female gender, lower education, and exposure to prior interpersonal trauma to the model yielded 
higher PTSD likelihood estimates, with similar model accuracy (predicted vs. raw probabilities: r=0.941). The current model could be adjusted 
for other traumatic circumstances and accommodate risk factors not captured by the ICPP (e.g., biological, social). In line with their use in 
general medicine, risk estimate models can inform clinical choices in psychiatry. It is hoped that quantifying individuals’ PTSD risk will be a 
first step towards systematic prevention of the disorder.
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Post-traumatic stress disorder (PTSD) is the most frequent psy-
chopathological consequence of traumatic events1,2. Chronic 
PTSD is tenacious, debilitating and frequently intractable3-9. 
Early PTSD symptoms are sensitive but non-specific predictors 
of chronic PTSD10. They subside in over 70% of those expressing 
them11-13, whilst few initially asymptomatic survivors develop 
delayed-onset PTSD14.
Early cognitive behavioral interventions significantly reduce 
the prevalence of PTSD, and their effect is stable8,15,16. These 
interventions, however, are resource-demanding, and unnec-
essary for low-risk survivors, whose symptoms subside sponta-
neously15,17. Thus, an accurate individual estimate of survivors’ 
risk for chronic PTSD is a prerequisite for efficient prevention 
and service planning18.
Previous studies have had difficulty producing such esti-
mates, due to the multiplicity, complexity and distributional 
variation of PTSD risk indicators. Additionally, most studies 
have attempted to predict cases (i.e., who will develop PTSD) 
rather than produce PTSD likelihood estimates for every par-
ticipant (i.e., how likely is a person to develop PTSD)19,20.
Longitudinal studies have nonetheless reported numer-
ous group-level PTSD risk indicators21,22, such as female gen-
der23,24, age23, education25, ethnicity26, lifetime exposure to 
traumatic events27, and marital status24. Several symptom-
based case predictions have been developed, consistently per-
forming better than chance28-31, but unable to build a reliable, 
personalized risk estimator32. Meta-analyses21,22 and system-
atic reviews21,22,33,34 have similarly endorsed group-level risk 
indicators without a clear path to clinical implementa tion34.
Trauma admissions to acute care centers and emergency 
departments (EDs) offer a first point of contact with numerous 
survivors at risk. EDs evaluate in the US over 39 million indi-
viduals yearly for treatment of traumatic injury35-39. Worldwide, 
road traffic accidents, a mainstay cause of ED admissions, 
cause an estimated 1.25 million deaths and over 20 million 
non-fatal injuries yearly40.
The prevalence of PTSD after ED admissions resembles that 
seen in survivors who do not require or receive ED care – e.g., 52% 
incidence of new PTSD among women survivors of interperson-
al violence admitted to EDs vs. 51-76% among women surveyed 
in shelters, domestic-violence clinics and therapy groups41,42. 
The 18-month prevalence of PTSD among drivers admitted to 
general hospitals after injury-producing car crashes (11%) is 
somewhat higher than that of car drivers not seen in EDs (7%)43.
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Quantifying individuals’ PTSD risk following acute care trau-
ma admission could provide an empirical foundation for miti-
gating and preventing a major public health issue. Towards that 
goal, members of the International Consortium to Predict PTSD 
(ICPP) shared item-level data from ten longitudinal, acute care 
based studies of the early development of PTSD, performed in 
the US, Australia, Japan, Israel, Switzerland, and The Nether-
lands. The data were harmonized, pooled into a single indi-
vidual participant-level dataset (IPD) and submitted to data 
analysis.
An analysis of IPD, or mega-analysis, offers a sensible ap-
proach to aggregating data across studies44,45. Unlike systematic 
reviews and meta-analyses, mega-analyses do not rely on the 
original studies’ data analytic approaches and reporting per-
spectives and enable direct estimates of parameters of interest 
(i.e., predictors, outcomes). This allows data source heteroge-
neity and subgroup variations to be examined directly, and 
makes it possible to interrogate the combined data in ways not 
considered, or impossible, in the component studies, due to 
their sample sizes or limited population diversity46,47.
In line with current medical risk assessment practices (e.g., 
in oncology48-50, surgery or cardiology51-54), we used the ICPP 
IPD to develop a prediction function that estimates the prob-
ability of PTSD given a set of early, observable risk indicators. 
Following replicated demonstrations of their predictive yield in 
classification models55-62, we positioned PTSD symptoms as a 
key predictor, subsequently enriching the predictive models by 
including other previously documented and clinically-obtain-
able risk indicators available in the ICPP dataset (e.g., gender, 
trauma type, lifetime trauma history).
METHODS
Studies, participants and variables
Using a previously described literature search strategy63, the 
ICPP IPD consisted of thirteen longitudinal acute-care based 
studies of recent trauma survivors conducted in six countries. 
Investigators obtained informed consent using procedures 
approved by their local institutional review boards. Item-level 
data from studies were shared, harmonized (see below) and 
combined into a pooled dataset. All ICPP studies used the 
DSM-IV PTSD template to infer PTSD diagnosis and symptom 
severity. Included in this report are the ten studies15,64-72 that 
used the repeatedly validated Clinician-Administered PTSD 
Scale for DSM-IV (CAPS)73,74.
Study participants were included if they had an initial CAPS 
interview within 60 days of the traumatic event, and at least one 
follow-up CAPS assessment 4 to 15 months (122 to 456 days) 
after trauma exposure. These criteria were met by 2,473 partic-
ipants (Table 1). To maximize the utility of prediction, we used 
the earliest observation for individuals with two early (<60 days) 
assessments, and the latest observation for those with multiple 
assessments during follow-up.
PTSD severity and diagnosis
The CAPS quantifies the frequency and severity of each of 
the seventeen DSM-IV PTSD symptom criteria73 by assigning 
to each symptom a 0-4 incremental frequency score and a 
0-4 intensity score. A continuous measure of PTSD severity is 
obtained by adding all individual symptom scores (CAPS total 
score). A diagnosis of PTSD is determined using DSM-IV PTSD 
diagnostic criteria of at least one re-experiencing (Criterion 
B), three avoidance/numbing (Criterion C), and two hypera-
rousal (Criterion D) symptoms73. Following recommendations, 
a PTSD symptom was deemed “present” if its frequency score 
was 1 or more, and its intensity score was 2 or more74,75.
Information on DSM-IV Criterion E (duration of at least one 
month) and F (clinically significant distress or impairment) 
were collected in four out of the ten studies. A sensitivity analy-
sis within these studies found very high concordance between 
diagnoses determined by meeting DSM-IV symptom crite-
ria alone (i.e., criteria B through D) and those obtained using 
both the symptom criteria and the E and F criteria (sensitivity 
0.92, specificity 1.00, Cohen’s kappa=0.95). We consequently 
assumed PTSD diagnosis as present, across studies, based on 
meeting DSM-IV PTSD symptom criteria alone.
Risk indicators
The study’s primary risk indicator was PTSD severity at 
the initial assessment (CAPS0, range 0-136), with age, gender, 
ethnicity, educational attainment, lifetime history of trauma 
exposure, and current trauma type considered as additional 
predictors.
Differences in data collection and instruments across stud-
ies required harmonization of four risk indicators. Educational 
attainment, which varied by participating countries’ schooling 
systems, was recoded into a binary variable of less than second-
ary education versus completion of at least secondary education. 
Recoding participants’ lifetime exposure to traumatic events fol-
lowed a previous demonstration of a strong association between 
interpersonal trauma and PTSD76 and included: a) exposure 
to at least one instance of interpersonal violence (e.g., physi-
cal or sexual violence, war or terror), b) in the absence of the 
former, exposure to at least one instance of non-interpersonal 
trauma (e.g., road traffic accidents), and c) no trauma exposure. 
Traumatic events leading to current acute care admission were 
categorized as motor vehicle accidents, other non-interpersonal 
events, and interpersonal violence (e.g., assaults).
Data completeness and handling missing observations
CAPS0 data were available for all 2,473 participants. Data on 
age, gender, and current trauma were available for >99% of the 
sample. Marital status was missing in 4.5%, education in 6.2%, 
ethnicity in 12.3%, and prior trauma in 16.8% of the sample.
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Participants missing at least one variable (N=791; 32%) dif-
fered from those with complete data (N=1,682) with respect 
to several risk indicators (Table 2). To address these missing 
observations, we present analyses in which missing predictors 
were handled by multiple imputation using chained equations 
(MICE) performed on the IPD77. Ten imputed datasets were 
created after twenty iterations and the results were pooled us-
ing Rubin’s method78. For completeness, we also computed the 
results using individuals who had complete data (i.e., without 
imputation). The results did not differ substantially from those 
obtained after imputation and are available upon request.
Data analyses
Differences in frequency and severity of risk predictors 
between participants with and without endpoint PTSD were 
assessed using Mann–Whitney tests for continuous risk predic-
tors and χ2 tests for categorical risk predictors. The number of 
participants endorsing each CAPS0 severity score (smoothed 
for five-points intervals) was visualized using a histogram, 
separately for all participants and for those with PTSD at the 
study’s endpoint.
The relatively large sample size in the ICPP dataset enabled 
us to obtain simple raw estimates of the probability of down-
stream PTSD for each CAPS0 score. The estimator used was 
the fraction of PTSD cases among all individuals with a given 
CAPS0 score, smoothed with a window of five adjacent points.
Logistic regression models were obtained using CAPS0 as 
the only predictor (CAPS0 model), CAPS0 plus all risk predic-
tors (full model), and CAPS0 plus significant predictors only 
(significant predictors model). The models’ fits were evaluated 
using the Brier score79, Efron’s R2, model’s predicted-to-raw 
ratio, and the area under the receiver operating characteristic 
curve (AUC).
The Brier score79 measures the accuracy of probabilistic pre-
dictions. It expresses the mean standard error of the squared 
difference between the estimated probabilities and the true 
PTSD classification. Its range is 0 to 1. A Brier score of zero 
represents a perfect model and scores of 0.25 or greater signal 
a non-informative model. Efron’s R2 is the correlation between 
the predicted probabilities and the smoothed probabilities.
Two options were considered for selecting the regression 
model’s intercept: a fixed effects intercept, where a common 
intercept is estimated after pooling or “stacking” the data to-
gether, and a random effects intercept, where the intercept is 
allowed to vary by study44. Random effects (or stratified ap-
proaches) have not been recommended when the prevalence 
of an outcome varies substantially between studies44, as is the 
case with the ICPP studies. Alternatively, it could be hypoth-
esized that heterogeneity in endpoint PTSD prevalence across 
ICPP studies reflected heterogeneity in the distribution of 
CAPS0 severity across studies, which was due to variability in 
studies’ sampling routine. Under this hypothesis, ICPP stud-
ies could be seen as representing different samplings from a 
common parent population of acute care trauma admissions.
To evaluate the two models, we compared the predictive fits 
of the fixed effects and the random effects logistic regressions 
with CAPS0 as the only predictor, using a bootstrap approach 
where participants were randomly sampled with replacement, 
models were obtained, and then predicted probabilities from 
both models were estimated among the left-out participants. 
For each approach, the ratio of expected PTSD diagnoses and 
actual PTSD diagnoses (expected/observed or E/O), the cali-
bration slope βoverall (the slope from a logistic regression of the 
predicted probabilities on endpoint PTSD), and the Brier score 
were obtained. An E/O far from 1 indicates whether the model’s 
intercept, which determines the predicted prevalence of PTSD, 
is too high or too low, while the calibration slope reflects het-
erogeneity of the predictor-outcome associations or over-fitting 
of the data44. This process was repeated 100 times with statistics 
averaged across iterations. A finding of poorer  results in the 
Table 2 Comparison of  participants with complete and incomplete 
data
Variable
Complete 
(N=1,682)
Incomplete 
(N=791) p
Age (mean±SD) 37.5±14.1 39.0±13.6 0.347
CAPS0 (mean±SD) 21.0±26.0 14.0±22.3 <0.001
Gender, N (%)
 Male 1,028 (66) 533 (34) <0.001
 Female 654 (72) 251 (28)
Ethnicity, N (%)
 White 1,502 (76) 481 (24) <0.001
 Non-White 180 (97) 5 (3)
Education, N (%)
 At least secondary education 1,389 (73) 505 (27) 0.057
 Less than secondary education 293 (69) 133 (31)
Marital status, N (%)
 Married/living with a partner 860 (74) 304 (26) 0.005
 Single/not living with a partner 822 (69) 375 (31)
Trauma type, N (%)
 Motor vehicle accident 1,285 (75) 421 (25) <0.001
 Other non-interpersonal 291 (47) 329 (53)
 Interpersonal 106 (77) 31 (23)
Prior trauma, N (%)
 None 298 (86) 49 (14) <0.001
 Non-interpersonal 626 (87) 93 (13)
 Interpersonal 758 (76) 233 (24)
Endpoint PTSD, N (%)
 No 1,474 (68) 708 (32) 0.178
 Yes 208 (71) 83 (29)
PTSD – post-traumatic stress disorder, CAPS0 – baseline score on Clinician-
Administered PTSD Scale for DSM-IV
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fixed effects model compared to the random effects model 
would indicate that the studies were too heterogeneous to be 
analyzed together after accounting for differences in the distri-
bution of CAPS0.
Differences in the predicted probability of PTSD given dif-
ferent risk factors were estimated by drawing 1,000 posterior 
simulations of each model’s β coefficients, predicting endpoint 
PTSD at each value of CAPS0 with different risk profiles (e.g., 
male versus female gender), and evaluating the differences 
in the predicted probabilities across baseline CAPS0 scores
80.
The selected time window for determining endpoint PTSD 
status (122-456 days; 4-15 months) maximized the number 
of ICPP studies included in each time interval. To evaluate 
whether the substantial width of that time window affected the 
results, and to additionally produce an estimate of prolonged 
PTSD likelihood, we repeated the logistic regressions using 
participants whose PTSD status was obtained 9 to15 months 
(273-456 days) after the traumatic events.
RESULTS
Participants’ characteristics, risk predictors, and CAPS0 
scores
Participants’ average age at studies’ onset was 39.0±13.9 years. 
There were fewer female participants (37%) in the sample than 
males. Motor vehicle accidents (69%) were the most common in-
Table 3 Sample variables stratified by endpoint post-traumatic stress disorder (PTSD) status
Variable No endpoint PTSD Endpoint PTSD Total sample p
N (%) 2,182 (88) 291 (12) 2,473
Age (mean±SD) 38.0±14.2 39.0±11.8 39.0±13.9 0.366
CAPS0 (mean±SD) 23.1±21.4 59.6±27.8 27.4±25.1 <0.001
Gender, N (%)
 Male 1,418 (91) 143 (9) 1,561 <0.001
 Female 757 (84) 148 (16) 905
 Missing 7 (0.3)
Ethnicity, N (%)
 White 1,742 (88) 241 (12) 1,983 0.592
 Non-White 165 (89) 20 (11) 185
 Missing 305 (12.3)
Education, N (%)
 At least secondary education 1,698 (90) 196 (10) 1,894 0.051
 Less than secondary education 368 (86) 58 (14) 426
 Missing 153 (6.2)
Marital status, N (%)
 Married/living with a partner 1,035 (89) 129 (11) 1,164 0.780
 Single/not living with a partner 1,060 (89) 137 (11) 1,197
 Missing 112 (4.5)
Current trauma type, N (%)
 Motor vehicle accident 1,485 (87) 221 (13) 1,706 <0.001
 Other non-interpersonal 588 (95) 32 (5) 620
 Interpersonal 100 (73) 37 (27) 137
 Missing 10 (0.4)
Prior trauma, N (%)
 None 308 (89) 39 (11) 347 0.061
 Non-interpersonal 641 (89) 78 (11) 719
 Interpersonal 848 (86) 143 (14) 991
 Missing 416 (16.8)
Comparisons (p values) are between participants with vs. without endpoint PTSD
CAPS0 – baseline score on Clinician-Administered PTSD Scale for DSM-IV
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dex trauma, followed by other types of non-interpersonal trauma 
(25%) and interpersonal trauma (6%). The median time to the 
initial assessment was 15±16.7 days (range 1-60). The median time 
to the endpoint assessment was 333±103.1 days (range 122-456).
The prevalence of endpoint PTSD was 11.8% (N=291). End-
point PTSD was significantly more frequent among female 
participants (16.4%, compared to 9.2% in males, p<0.001) and 
among participants who suffered interpersonal trauma com-
pared to a motor vehicle accident or other traumatic events (re-
spectively, 27%, 5% and 13%, p<0.001). No significant differences 
were observed by ethnicity, marital status, or age (see Table 3).
The histogram in Figure 1 displays the number of partici-
pants who endorsed each CAPS0 score, smoothed for a five 
points interval. As can be seen, the total number of partici-
pants declines progressively with increasing CAPS0 scores. The 
CAPS0 scores of participants with endpoint PTSD, however, 
span across the instrument’s severity range, such that the pro-
portion of those with endpoint PTSD increases with increasing 
CAPS0 severity.
Prediction of endpoint PTSD
The results from fixed effect models using CAPS0 alone 
(CAPS0 model), CAPS0 plus all available predictors (full model), 
and CAPS0 plus significant predictors only (significant predic-
tors model) are presented in Table 4.
The CAPS0 model (plotted in Figure 2 along with its 95% con-
fidence interval) fits well (Efron’s R2=0.230, Brier score=0.080, 
AUC=0.847), with a very high correlation between the model’s 
predicted probability and the smoothed estimate of conditional 
probability (r=0.976). Logistic regression using the full mod-
el showed that female gender (β=0.309, SE=0.151, p=0.041), 
having less than a secondary education (β=0.486, SE=0.188, 
p=0.009), and prior interpersonal trauma (β=0.662, SE=0.238, 
p=0.006) contributed significantly to the PTSD outcome.
With the inclusion of all risk indicators (full model) or that of 
significantly contributing factors (significant predictors mod-
el), accuracy remained high (respectively, smoothed prob-
ability correlation=0.941, Efron’s R2=0.246, Brier score=0.078, 
AUC=0.855; and smoothed probability correlation=0.946, Efron’s 
R2=0.246, Brier score=0.078, AUC=0.851). Thus, the addition of 
female gender, lifetime exposure to interpersonal violence, and 
less than a secondary education to the CAPS0 model increased 
PTSD likelihood whilst keeping the CAPS0 model’s accuracy.
In the bootstrap analysis comparing the fixed effects logistic 
model with a random effects model using only CAPS0 as a pre-
dictor, the E/O ratio and βoverall from the fixed effects model (1.01 
and 1.00, respectively) were closer to 1.00 than the random ef-
fects model (1.14 and 0.75, respectively), and the Brier score was 
lower on average for the fixed effects model (0.081, SD=0.01) 
than the random effects model (0.084, SD=0.01). Overall, the 
fixed effects model seems to estimate the likely number of par-
ticipants with PTSD at follow-up more accurately, with less 
heterogeneity or over-fitting, than the random effects model, 
thereby supporting the pooling of participating studies.
After accounting for the CAPS0 effect, female participants 
were found to have a maximum of 5% (95% CI: –2% to 12%) 
higher risk for endpoint PTSD compared to male participants. 
Moreover, participants with all significant risk factors (i.e., 
Figure 1 Histogram of participants’ baseline PTSD symptoms severity scores (CAPS0 total scores). Dots represent individual participants; 
overlayed triangles those who subsequently developed PTSD. PTSD – post-traumatic stress disorder, CAPS0 – baseline score on Clinician-
Administered PTSD Scale for DSM-IV.
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female gender, less than secondary education, and exposure 
to prior interpersonal trauma) had a 34% (95% CI: 20-48%) 
higher risk of PTSD compared to participants without any 
significant risk factors (i.e., male with secondary education 
and no prior interpersonal trauma). Estimated probabilities 
and 95% confidence intervals for endpoint PTSD based on 
each combination of the significant predictors are provided 
in Table 5.
Table 4 Coefficients (with SE) and fit statistics from the CAPS0, significant predictors and full models
Model parameters CAPS0 model Significant predictors model Full model
Intercept –3.981*** (0.149) –4.628*** (0.27) –4.659*** (0.377)
CAPS0 0.05*** (0.003) 0.051*** (0.003) 0.05*** (0.003)
Female - 0.307* (0.149) 0.309* (0.151)
Age - - 0 (0.006)
Less than secondary education - 0.483** (0.186) 0.486** (0.188)
Non-White - - 0.42 (0.281)
Single - - 0.051 (0.164)
Current traumatic event
 Interpersonal - - 0.286 (0.255)
 Other - - –0.201 (0.222)
Lifetime trauma exposure
 Non-interpersonal - 0.113 (0.249) 0.128 (0.249)
 Interpersonal - 0.656** (0.237) 0.662** (0.238)
Efron’s R2 0.23 0.246 0.246
Smoothed probability correlation 0.976 0.946 0.941
Brier score 0.08 0.078 0.078
AUC 0.847 0.851 0.855
*p<0.05, **p<0.01, ***p<0.001
CAPS0 – baseline score on Clinician-Administered PTSD Scale for DSM-IV, AUC – area under receiver operating characteristic curve
Figure 2 Predicted probabilities of endpoint PTSD conditional on initial (CAPS0) severity scores. The dots represent the raw conditional prob-
ability of PTSD at follow-up given the CAPS0 score, smoothed with a kernel of width 5. The solid black line represents the logistic model predicted 
probability given the CAPS0 score. The gray area is the 95% confidence interval for the prediction model. The dashed line represents the predic-
tion function derived from participants with follow-up observations later than 9 months. PTSD – post-traumatic stress disorder, CAPS0 – baseline 
score on Clinician-Administered PTSD Scale for DSM-IV.
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Using data from participants whose last follow-up assessment 
fell between 9 and 15 months from the traumatic event (N=1,359) 
to fit a CAPS0-only logistic regression yielded similar predic -
tion probabilities (see dotted line in Figure 2), with similar model 
accuracy (Efron’s R2=0.195, Brier score=0.071, AUC=0.822).
DISCUSSION
The results of this study demonstrate that the probability of 
meeting PTSD diagnostic criteria 4 to 15 months after acute 
care admission is reliably modeled by a logistic function of 
initial PTSD symptom severity. Added to this model, female 
gender, having less than secondary education, and prior in-
terpersonal trauma were associated with higher likelihood of 
endpoint PTSD. Other previously documented risk factors, 
such as age, marital status, and current trauma type, did not 
improve the prediction over the model that had CAPS0 score 
as the only predictor. Importantly, the limited margin of error 
of the resulting risk estimate enables its clinical use to assess 
PTSD likelihood for each combination of the significant risk 
indicators.
The limited incremental effect of several known risk factors 
was an unexpected finding, suggesting that the contribution of 
Table 5 Estimated probabilities (with 95% CIs) of  endpoint PTSD diagnosis by incremental values of  CAPS0 scores
CAPS0 total  
score
Probability of PTSD
(CAPS0 alone)
Probability of PTSD by gender
(CAPS0 plus gender)
Probability of PTSD by gender
(CAPS0, plus less than secondary education, and 
prior interpersonal trauma)
Males Females Males Females
0 0.018 (0.014-0.024) 0.017 (0.013-0.023) 0.021 (0.015-0.029) 0.030 (0.020-0.043) 0.041 (0.025-0.061)
5 0.024 (0.018-0.030) 0.022 (0.017-0.029) 0.027 (0.020-0.037) 0.038 (0.026-0.054) 0.052 (0.033-0.076)
10 0.03- (0.024-0.038) 0.028 (0.021-0.036) 0.034 (0.025-0.046) 0.049 (0.034-0.068) 0.065 (0.042-0.095)
15 0.038 (0.031-0.047) 0.035 (0.028-0.045) 0.043 (0.033-0.056) 0.062 (0.044-0.085) 0.083 (0.054-0.119)
20 0.048 (0.040-0.059) 0.045 (0.036-0.056) 0.055 (0.042-0.070) 0.079 (0.056-0.106) 0.104 (0.070-0.147)
25 0.061 (0.051-0.073) 0.057 (0.046-0.069) 0.069 (0.054-0.086) 0.099 (0.071-0.132) 0.130 (0.089-0.181)
30 0.077 (0.066-0.090) 0.071 (0.059-0.086) 0.086 (0.069-0.106) 0.124 (0.091-0.163) 0.161 (0.113-0.220)
35 0.097 (0.084-0.112) 0.090 (0.075-0.106) 0.108 (0.088-0.130) 0.154 (0.114-0.201) 0.198 (0.142-0.265)
40 0.121 (0.106-0.138) 0.112 (0.094-0.132) 0.134 (0.111-0.161) 0.190 (0.143-0.245) 0.241 (0.177-0.317)
45 0.150 (0.133-0.169) 0.139 (0.117-0.162) 0.165 (0.139-0.195) 0.232 (0.177-0.296) 0.290 (0.218-0.375)
50 0.185 (0.165-0.207) 0.171 (0.145-0.199) 0.202 (0.172-0.235) 0.280 (0.217-0.352) 0.345 (0.264-0.436)
55 0.226 (0.201-0.251) 0.208 (0.176-0.241) 0.244 (0.209-0.284) 0.334 (0.262-0.413) 0.404 (0.315-0.500)
60 0.272 (0.243-0.302) 0.252 (0.213-0.292) 0.293 (0.253-0.337) 0.392 (0.312-0.477) 0.466 (0.372-0.564)
65 0.324 (0.289-0.360) 0.301 (0.256-0.349) 0.346 (0.300-0.393) 0.453 (0.367-0.543) 0.528 (0.431-0.626)
70 0.381 (0.340-0.423) 0.355 (0.302-0.410) 0.404 (0.352-0.455) 0.516 (0.425-0.608) 0.590 (0.492-0.685)
75 0.442 (0.394-0.488) 0.413 (0.353-0.475) 0.464 (0.406-0.519) 0.579 (0.484-0.670) 0.649 (0.553-0.739)
80 0.504 (0.450-0.555) 0.474 (0.409-0.540) 0.525 (0.463-0.582) 0.638 (0.544-0.726) 0.704 (0.612-0.787)
85 0.566 (0.507-0.621) 0.535 (0.465-0.604) 0.586 (0.519-0.644) 0.694 (0.602-0.776) 0.754 (0.668-0.829)
90 0.625 (0.564-0.682) 0.595 (0.524-0.665) 0.644 (0.576-0.702) 0.745 (0.657-0.819) 0.797 (0.720-0.864)
95 0.682 (0.619-0.738) 0.653 (0.579-0.722) 0.698 (0.631-0.752) 0.790 (0.708-0.855) 0.835 (0.765-0.893)
100 0.733 (0.671-0.787) 0.706 (0.632-0.772) 0.747 (0.682-0.798) 0.828 (0.754-0.886) 0.867 (0.805-0.916)
105 0.778 (0.719-0.830) 0.754 (0.682-0.816) 0.790 (0.729-0.838) 0.861 (0.795-0.911) 0.893 (0.840-0.934)
110 0.818 (0.763-0.864) 0.796 (0.730-0.853) 0.828 (0.769-0.871) 0.888 (0.830-0.931) 0.915 (0.869-0.949)
115 0.852 (0.801-0.893) 0.833 (0.773-0.883) 0.860 (0.807-0.899) 0.911 (0.861-0.946) 0.932 (0.894-0.961)
120 0.881 (0.835-0.917) 0.864 (0.809-0.909) 0.887 (0.839-0.921) 0.929 (0.887-0.959) 0.947 (0.915-0.970)
125 0.904 (0.864-0.935) 0.890 (0.840-0.929) 0.909 (0.867-0.938) 0.944 (0.908-0.968) 0.958 (0.931-0.977)
130 0.924 (0.888-0.950) 0.912 (0.868-0.945) 0.927 (0.890-0.952) 0.956 (0.926-0.976) 0.967 (0.945-0.982)
135 0.939 (0.909-0.962) 0.929 (0.892-0.957) 0.942 (0.910-0.963) 0.965 (0.940-0.981) 0.974 (0.956-0.986)
PTSD – post-traumatic stress disorder, CAPS0 – baseline score on Clinician-Administered PTSD Scale for DSM-IV. For the full array of  risk indicator combina-
tions, see https://wvdmei.shinyapps.io/PTSD_Risk_Lookup/.
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these factors to PTSD likelihood is mediated by their effect on 
early symptom severity. In line with this view, a previous com-
parison of PTSD following terror attacks with PTSD following 
motor vehicle accidents from the same ED has shown that the 
higher prevalence of 4-month PTSD following terror attacks 
(38% vs. 19%) was entirely accounted for by survivors’ early 
responses, that included one-week PTSD symptoms, ED heart 
rate and peri-traumatic dissociation61.
Our results extend previous findings of an association be-
tween high initial PTSD symptoms and being diagnosed with 
PTSD55-62 by highlighting the added informational value of 
likelihood estimates relative to predictive classification. The 
uniform distribution of PTSD participants initial CAPS0 scores 
illustrates a barrier to classification models: trauma survivors 
who ultimately developed PTSD had their initial symptom se-
verity distributed across the entire range of CAPS0 total scores, 
thereby defying the use of a threshold separating future cases 
from non-cases. Predicting who will develop PTSD, as much 
as predicting who among heavy smokers will develop lung 
cancer, is a difficult task, frequently replaced by likelihood 
estimates. Classification models have significantly informed 
our understanding of disorders’ etiology and pathogenesis81-86. 
Likelihood estimates, however, may be better suited for quan-
tifying individual risk. As in other areas of medicine48-54, quan-
tifying risk ultimately informs clinical action.
How can our results inform clinical action? Consider, for 
example, three female survivors with a CAPS0 score of, respec-
tively, 20, 40, 60; less than secondary education, and lifetime 
exposure to interpersonal violence. These individuals will have, 
respectively, 10.4% (95% CI: 7.0-14.7), 24.1% (95% CI: 17.7-31.7) 
and 46.6% (95% CI: 37.2-56.4) likelihood of chronic PTSD. Male 
survivors with the same initial scores and no additional risk 
factors will have, respectively, 2.7% (95% CI: 1.8-4.0), 7.1% (95% 
CI: 4.8-10.1) and 17.3% (95% CI: 12.2-23.4) likelihood of chronic 
PTSD. Individuals endorsing the highest CAPS0 score, in both 
genders, might be seen as requiring clinical attention, e.g., an 
early intervention. The lower scores may justify a “watchful 
wait” with additional assessments.
A strength of this study follows from the use of data on a 
large number of participants from culturally and geographi-
cally diverse settings. Each included investigation utilized a 
longitudinal design, assessed PTSD symptoms shortly after 
index trauma, and based its appraisal of symptoms and di-
agnostic status on the repeatedly validated CAPS instrument.
In interpreting our findings, one should nonetheless con-
sider some limitations. First, the time frame to determine PTSD 
status in our main analyses was 4-15 months, thus very wide. 
However, when the data were restricted to participants re-
interviewed more than 9 months after the trauma, the resulting 
logistic prediction model remained essentially unchanged. Our 
prediction is nonetheless calibrated for the wider and earlier 
time bracket and centered on 333.0±103.1 days (less than a 
year) from trauma exposure.
Second, several risk predictors were harmonized due to the 
variety of instruments used by site investigators, which resulted 
in a loss of granularity. While those harmonized variables (less 
than secondary education, lifetime interpersonal trauma) have 
contributed to PTSD probability estimates, results involving 
recoded variables may miss important predictors’ information. 
Simplified predictors, however, might be easier to obtain in clin-
ical practice and are widely used in predictive models in other 
areas of medicine (e.g., “smoking yes/no” and “diabetes yes/no” 
in the Framingham 10 years cardiovascular disease risk score).
Third, the ICPP data display considerable heterogeneity 
among contributing studies, which, as discussed above, raised 
methodological concerns about the best approach to pooling 
the data. We found that the fixed effects model was more accu-
rate than the data source dependent random effects model and 
thus justified pooling from different studies. We also believe 
that a fixed effects model is more applicable to new environ-
ments, because a global slope and intercept were estimated 
across studies. Our choice, however, is neither beyond critique 
nor without significance: large multi-source data compila-
tions are currently evaluated in genetic, genomic and imaging 
research87, all of which have to contend with data source het-
erogeneity resembling the ICPP effort. Our theoretical premise 
that ICPP studies were differentially sampling subsets of an 
underlying population of reference (i.e., acute care trauma ad-
missions) should be corroborated by testing the resulting risk 
assessment tool in newly admitted acute care trauma survivors.
The use of the CAPS structured clinical interview may add 
some burden on service delivery, and that interview is not prop-
erly a screening instrument. Moreover, several PTSD (i.e., CAPS) 
symptoms (e.g., insomnia, avoidance, inability to recall impor-
tant aspects of the traumatic event) may not be present during 
ED admission. The early CAPS, nonetheless, is a robust risk indi-
cator. Future work should explore earlier and simpler screening 
alternatives, or establish stepwise “screening and prediction” 
models, starting upon ED admission and predicting the likeli-
hood of expressing high levels of early PTSD symptoms.
Finally, our model was developed using acute care trauma 
admissions, and as such its implementation in other traumatic 
circumstances (e.g., prolonged adversities such as wars, captiv-
ity and relocation) may require adjustments. Notwithstanding 
the precise risk estimates for other traumatic circumstances, 
we believe that early symptom severity has been convincingly 
shown here to be a major predictor of PTSD risk, and that, as 
such, its evaluation among individual survivors provides a valid 
warning and a call for action.
These limitations do not take away from the robustness of 
our likelihood estimates and their ability to support a personal 
risk assessment in individual survivors. Similar risk estimate 
tools are used in other medical domains to support clinical 
decisions (e.g., for determining breast48 or lung49,50 cancer like-
lihood given risk indicators). The risk estimates provided in this 
work can be similarly used to trigger action (either watchful 
follow-up or early intervention) according to local resources 
and the desirability of prevention.
Quantifying individual risk is a step forward in planning ser-
vices and interventions, better targeting high-risk individuals, 
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and ultimately decreasing the burden of PTSD following acute 
care admission.
APPENDIX
Members of the International Consortium to predict PTSD include: Yael Errera-
Ankri, Anna C. Barbano, Sarah Freedman, Jessie Frijling, Carel Goslings, Jan Lui-
tse, Alexander McFarlane, Derrick Silove, Hanspeter Moergeli, Joanne Mou-
thaan, Daisuke Nishi, Meaghan O’Donnell, Marit Sijbrandij, Sharain Suliman and 
Mirjam van Zuiden.
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